67457-693 NDC - FONDAPARINUX SODIUM ()

Drug Information

No.	Package Code	Package Description	Billing Unit
1	67457-693-10	10 SYRINGE in 1 CARTON (67457-693-10) / .5 mL in 1 SYRINGE (67457-693-00)	ML

Field Name	Field Value	Definition
PRODUCT NDC	67457-693	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAME	Fondaparinux Sodium	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE	6/9/2016	Name of Company corresponding to the labeler code segment of the Product NDC.
END MARKETING DATE	1/31/2019	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
MARKETING CATEGORY NAME	NDA
APPLICATION NUMBER	NDA021345	This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAME	Mylan Institutional LLC	Name of Company corresponding to the labeler code segment of the Product NDC.